Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 19Terminated 7Recruiting 6Unknown 3Enrolling by invitation 2Withdrawn 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Classical hematology 1

Conditions

Venous Thromboembolism 1Urinary Bladder Neoplasms 1Sarcoma 1Hematoma 1Bone Neoplasms 1

Interventions

Cisplatin 9Standard of Care 6Educational Status 6Nivolumab 5Interviews as Topic 5Carboplatin 5Radiotherapy 4Paclitaxel 4Oxaliplatin 4Fluorodeoxyglucose F18 4Dexamethasone 4pembrolizumab 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Lenalidomide 3Fluorouracil 3Exercise 3Early Intervention, Educational 3Drug Therapy 3Cytarabine 3130-nm albumin-bound paclitaxel 3venetoclax 2toripalimab 2tislelizumab 2sacituzumab govitecan 2lenvatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Enoxaparin × Clear all
NCT06243510 2026-01-28

CARE

Abramson Cancer Center at Penn Medicine

Phase NA Enrolling by invitation
90 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡